Project Details
Description
Phase II Trial of Neoadjuvant Nivolumab with Cisplatin and Gemcitabine in Muscle-Invasive Bladder Cancer (MIBC) Patients undergoing Radical Cystectomy
| Status | Active |
|---|---|
| Effective start/end date | 5/1/17 → 11/12/27 |
Funding
- BRISTOL-MYERS SQUIBB COMPANY
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.